Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2009 Results
Date:8/10/2009

74,549 1,306,762 Net loss $(12,392,101) $(13,494,882) $(18,896,088) $(32,691,011) ============ ============ ============ ============ Basic and diluted net loss per share attributable to common stockholders $(0.46) $(0.51) $(0.71) $(1.23) ====== ====== ====== ====== Shares used in calculation of basic and diluted net loss per share attributable to common stockholders 26,900,841 26,649,439 26,777,159 26,648,892 ========== ========== ========== ========== VANDA PHARMACEUTICALS INC. (A Development Stage Enterprise) CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) June 30, 2009 December 31, 2008 ------------- ----------------- ASSETS Current assets: Cash and cash equivalents $24,014,203 $39,079,304 Marketable securities 5,008,623 7,378,798 Prepaid expenses, deposits and other current assets 1,129,194 1,287,400 Inventory 1,272,240 - --------- --------- Total current assets 31,424,260 47,745,502 Property and equipment, net 1,518,442 1,758,111 Restricted cash 430,230 430,230 Intangible asset, net 11,770,648 - ---------- ---------- Total assets $45,143,580 $49,933,843 ==
'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
6. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
7. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results
8. Vanda Pharmaceuticals Reports First Quarter 2009 Results
9. Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
10. Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
11. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 With bed bugs' presence ... that although bed bugs need to be eliminated, one must ... compromise a person's health. And so to help bed bug ... get rid of bed bugs without using harmful ... bug spray it called Bed Bug Bully. , According to ...
(Date:5/20/2013)... PA (PRWEB) May 20, 2013 Interventional ... Allegheny General Hospital (AGH) Cardiovascular Institute have ... coronary artery disease (CAD) over the past ... such as balloon angioplasty and coronary artery stent implantation. ... once again play a prominent role in the study ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 In Early ... the field of biotoxin related illnesses , announced his ... country able to advance his protocol for treating Chronic ... became the third physician to achieve certification in the ... Physicians, able to practice the Shoemaker Protocol in other ...
(Date:5/17/2013)... GA (PRWEB) May 17, 2013 Dr. ... Gynecology, and Women’s Health at the Albert Einstein College ... Oncology at the Montefiore Medical Center. He is ... Cancer Center and leads the Einstein Breast Cancer Working ... on translational breast cancer research. He also serves as ...
Breaking Biology Technology:New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3
... BOTHELL, WA and VANCOUVER, May 11 /PRNewswire-FirstCall/ - ... announced today that final survival data from a ... with docetaxel versus docetaxel alone as first-line chemotherapy ... be featured in an oral presentation at the ...
... manufacturer, Sepha Ltd, enters strategic European alliances and gears up for ... , ... Belfast (Vocus) May 11, 2009 -- The ... de-blistering equipment, Sepha Ltd is boosting its European distribution ...
... attempt to dismiss Bavarian Nordic,s patent infringement suit in ... Biomedica,made yet another attempt to dismiss the suit arguing ... clinical trials. The court ruled,against Oxford Biomedica and the ... patents. , Bavarian Nordic owns ...
Cached Biology Technology:OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting 2OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting 3Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution 2Pharmaceutical Packaging Equipment Manufacturer Boosts European Distribution 3The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica 2
(Date:5/17/2013)... State University of New Jersey, and City University of ... Visikol TM that effectively clears organisms to be ... of chloral hydrate, which is one of the few ... regulated by the Drug Enforcement Administration (DEA) due to ... clearing agents, are vital for viewing organisms under a ...
(Date:5/17/2013)... proteins in the brain responsible for protecting nerve cells ... increase cell survival. , The discovery, made by researchers ... the EMBO journal with additional comment in ... stroke and other brain diseases. , The research builds ... protein, known as SUMO, responsible for controlling the chemical ...
(Date:5/17/2013)... project (Intelligent Cargo in Efficient and Sustainable Global Logistics ... an improvement in the efficiency of intermodal loading systems ... making. It comprises 29 European organisations with experience in ... has a budget totalling 17,000,000 and a duration of ... to specify and develop the semantic components and ontologies ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3SUMO wrestling cells reveal new protective mechanism target for stroke 2New logistics services that will cut energy consumption and CO2 emissions 2
... Leading bioscience funding bodies in the UK and USA ... transformational area of enhanced photosynthesis. The Biotechnology and ... Science Foundation (NSF) announce plans to hold an intensive ... in California later this year, to bring together leading ...
... of Cedars-Sinai Medical Center in Los Angeles, was presented ... annual Lifetime Achievement Award at its 2010 Annual Meeting. ... of contributions to genetic medicine, for his research into ... for helping to organize the field of medical genetics ...
... new tool to help marine biologists better grasp the processes ... unveil the bacterial community dynamics behind afflictions that bleach and ... March 30, 2010.) Warming waters are triggering coral ... Barrier Reef off the Australian coast. Now new mathematical models ...
Cached Biology News:BBSRC and NSF join together to promote new ideas to enhance photosynthesis 2Leader in genetics, Dr. David L. Rimoin, receives ACMG Foundation Lifetime Achievement Award 2Leader in genetics, Dr. David L. Rimoin, receives ACMG Foundation Lifetime Achievement Award 3New mathematical model helps biologists understand how coral dies in warming waters 2
... This adapter allows ... (AB-0800 and AB-1000) PCR ... in the ABI PRISM® ... contact ABgene® for information ...
... Heat activated ,• Eliminates nonspecific ... ,• Excellent specificity allows extension through ... structures ,• Leaves an 'A' overhang ... form of GeneChoice DNA Polymerase that ...
... aqueous solution. Cleaves a-(1-3)- ... carbohydrates and glycoproteins. It is particularly efficient ... the pH must be neutral or above, ... Unit Definition: One unit will ...
This adapter allows the Thermo-Fast® 96 Semi-Skirted (AB-0900 and AB-0990) PCR plates to be used directly in the ABI PRISM® 3100 sequencer without the need for software changes....
Biology Products: